tipifarnib has been researched along with azd2014 in 1 studies
Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (azd2014) | Trials (azd2014) | Recent Studies (post-2010) (azd2014) |
---|---|---|---|---|---|
309 | 92 | 94 | 76 | 8 | 72 |
Protein | Taxonomy | tipifarnib (IC50) | azd2014 (IC50) |
---|---|---|---|
Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | 3.8 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 3.8 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0521 | |
Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.2 | |
Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babic, T; Buric, SS; Dinic, J; Hadzic, S; Pesic, M; Radojkovic, D; Rankov, AD | 1 |
1 other study(ies) available for tipifarnib and azd2014
Article | Year |
---|---|
Comparative toxicity evaluation of targeted anticancer therapeutics in embryonic zebrafish and sea urchin models.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Arbacia; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Embryonic Development; Enzyme Inhibitors; Molecular Targeted Therapy; Morpholines; Oxadiazoles; Pyrimidines; Quinolones; Signal Transduction; Wortmannin; Zebrafish | 2018 |